Allena Pharmaceuticals Inc. (NASDAQ:ALNA) Stock Surges 17% After The FDA News
Allena Pharmaceuticals Inc. (NASDAQ:ALNA) was up 17% after the company announced that ALLN-346, its oral, urate-degrading enzyme, has been awarded Fast track Designation by the US FDA. Trading Data On Wednesday, ALNA stock soared 17% at $1 with more than 131.49 million shares, compared to its average volume of 952k shares. The stock has moved within a range of $0.9300 – 1.1700 after opening the trade at $1.04. Fast Track…